Metraipolis › archive › dc_6b2b60429ef4
The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy — Europe PMC PMID:42211735
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42211735
- DOI
- 10.1016/j.mmr.2026.100038
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T14:43:07.233Z
- SHA-256 of the archived text
d8cef731eca250e4a0bb27da420ec970af68eecc2999f1bdc04ae611209e8686- Stable URL of this page
https://metraipolis.com/documento/dc_6b2b60429ef4
How to cite
The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy — Europe PMC PMID:42211735 — Europe PMC (en), https://europepmc.org/article/MED/42211735 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6b2b60429ef4 (Metraipolis archive dc_6b2b60429ef4, sha256 d8cef731eca250e4a0bb27da420ec970af68eecc2999f1bdc04ae611209e8686)
BibTeX
@misc{dc6b2b60429ef4,
title = {The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy — Europe PMC PMID:42211735},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42211735},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6b2b60429ef4; sha256 d8cef731eca250e4a0bb27da420ec970af68eecc2999f1bdc04ae611209e8686},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42211735. Agents can read the archived copy with the MCP tool read_document.